A detailed history of Russell Investments Group, Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 43,196 shares of CRL stock, worth $8.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,196
Previous 41,376 4.4%
Holding current value
$8.62 Million
Previous $8.55 Million 0.44%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $342,087 - $446,427
1,820 Added 4.4%
43,196 $8.51 Million
Q2 2024

Aug 08, 2024

BUY
$206.39 - $268.73 $887,889 - $1.16 Million
4,302 Added 11.6%
41,376 $8.55 Million
Q1 2024

May 08, 2024

BUY
$203.52 - $273.43 $1.82 Million - $2.45 Million
8,959 Added 31.87%
37,074 $10 Million
Q4 2023

Feb 05, 2024

BUY
$164.52 - $238.84 $692,958 - $1.01 Million
4,212 Added 17.62%
28,115 $6.65 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $342,214 - $382,993
1,760 Added 7.95%
23,903 $4.68 Million
Q2 2023

Aug 10, 2023

BUY
$183.71 - $210.25 $448,987 - $513,851
2,444 Added 12.41%
22,143 $4.66 Million
Q1 2023

May 09, 2023

SELL
$191.89 - $259.92 $652,042 - $883,208
-3,398 Reduced 14.71%
19,699 $3.98 Million
Q4 2022

Feb 08, 2023

BUY
$197.11 - $250.07 $1.05 Million - $1.34 Million
5,344 Added 30.1%
23,097 $5.03 Million
Q3 2022

Nov 04, 2022

SELL
$182.44 - $250.54 $185,906 - $255,300
-1,019 Reduced 5.43%
17,753 $3.48 Million
Q2 2022

Jul 29, 2022

BUY
$204.13 - $302.4 $240,261 - $355,924
1,177 Added 6.69%
18,772 $4.02 Million
Q1 2022

May 05, 2022

SELL
$255.51 - $362.11 $2.74 Million - $3.89 Million
-10,737 Reduced 37.9%
17,595 $5.01 Million
Q4 2021

Jan 21, 2022

SELL
$351.38 - $448.68 $1.86 Million - $2.37 Million
-5,282 Reduced 15.71%
28,332 $10.7 Million
Q3 2021

Nov 08, 2021

BUY
$372.64 - $458.3 $2.49 Million - $3.06 Million
6,669 Added 24.75%
33,614 $13.9 Million
Q2 2021

Aug 04, 2021

SELL
$294.17 - $371.65 $599,224 - $757,051
-2,037 Reduced 7.03%
26,945 $9.97 Million
Q1 2021

May 10, 2021

SELL
$249.67 - $299.48 $1.03 Million - $1.23 Million
-4,110 Reduced 12.42%
28,982 $8.39 Million
Q4 2020

Feb 08, 2021

SELL
$222.0 - $252.62 $54,834 - $62,397
-247 Reduced 0.74%
33,092 $8.26 Million
Q3 2020

Nov 09, 2020

SELL
$175.56 - $226.45 $2.07 Million - $2.66 Million
-11,766 Reduced 26.09%
33,339 $7.53 Million
Q2 2020

Aug 05, 2020

SELL
$118.84 - $189.72 $501,980 - $801,377
-4,224 Reduced 8.56%
45,105 $7.81 Million
Q1 2020

May 06, 2020

BUY
$98.9 - $178.34 $965,956 - $1.74 Million
9,767 Added 24.69%
49,329 $6.29 Million
Q4 2019

Jan 29, 2020

SELL
$126.05 - $152.76 $4.5 Million - $5.45 Million
-35,667 Reduced 47.41%
39,562 $6.03 Million
Q3 2019

Nov 01, 2019

SELL
$125.07 - $143.67 $206,490 - $237,199
-1,651 Reduced 2.15%
75,229 $9.97 Million
Q2 2019

Aug 09, 2019

SELL
$123.4 - $148.55 $5.66 Million - $6.82 Million
-45,881 Reduced 37.37%
76,880 $10.8 Million
Q1 2019

May 13, 2019

BUY
$104.82 - $146.73 $2.44 Million - $3.41 Million
23,271 Added 23.39%
122,761 $17.7 Million
Q4 2018

Feb 11, 2019

BUY
$105.09 - $137.23 $1.61 Million - $2.11 Million
15,350 Added 18.24%
99,490 $11.2 Million
Q3 2018

Oct 26, 2018

SELL
$112.11 - $134.54 $2.24 Million - $2.69 Million
-20,005 Reduced 19.21%
84,140 $11.3 Million
Q2 2018

Aug 08, 2018

SELL
$102.37 - $117.25 $7.33 Million - $8.4 Million
-71,641 Reduced 40.75%
104,145 $11.6 Million
Q1 2018

May 11, 2018

BUY
$98.19 - $115.2 $3.97 Million - $4.66 Million
40,462 Added 29.9%
175,786 $18.8 Million
Q4 2017

Feb 06, 2018

BUY
$100.43 - $118.09 $614,430 - $722,474
6,118 Added 4.74%
135,324 $14.8 Million
Q3 2017

Nov 07, 2017

BUY
$96.72 - $109.26 $12.5 Million - $14.1 Million
129,206
129,206 $14 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.